Cargando…
Blockade of Cannabinoid CB1 Receptors in the Dorsal Periaqueductal Gray Unmasks the Antinociceptive Effect of Local Injections of Anandamide in Mice
Divergent results in pain management account for the growing number of studies aiming at elucidating the pharmacology of the endocannabinoid/endovanilloid anandamide (AEA) within several pain-related brain structures. For instance, the stimulation of both Transient Receptor Potential Vanilloid type...
Autores principales: | Mascarenhas, Diego C., Gomes, Karina S., Sorregotti, Tatiani, Nunes-de-Souza, Ricardo L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632997/ https://www.ncbi.nlm.nih.gov/pubmed/29046638 http://dx.doi.org/10.3389/fphar.2017.00695 |
Ejemplares similares
-
Anandamide in the dorsal periaqueductal gray inhibits sensory input without a correlation to sympathoexcitation
por: Roberts, Christopher J., et al.
Publicado: (2022) -
Electroacupuncture reduces chronic itch via cannabinoid CB1 receptors in the ventrolateral periaqueductal gray
por: Ge, Wen-Qiang, et al.
Publicado: (2022) -
Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?
por: Moreira, F. A., et al.
Publicado: (2009) -
Ventrolateral periaqueductal gray matter integrative system of defense and antinociception
por: de Mello Rosa, Gustavo Henrique, et al.
Publicado: (2022) -
Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray
por: Wilson-Poe, Adrianne R., et al.
Publicado: (2021)